We are live on ! Find out more

1,063 hedge funds and large institutions have $28.3B invested in Xylem in 2025 Q2 according to their latest regulatory filings, with 129 funds opening new positions, 393 increasing their positions, 392 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more call options, than puts

Call options by funds: $57.4M | Put options by funds: $20.6M

63% more first-time investments, than exits

New positions opened: 129 | Existing positions closed: 79

11% more funds holding in top 10

Funds holding in top 10: 910 (+1)

5% more capital invested

Capital invested by funds: $26.9B → $28.3B (+$1.42B)

4% more funds holding

Funds holding: 1,0261,063 (+37)

0% more repeat investments, than reductions

Existing positions increased: 393 | Existing positions reduced: 392

2.82% less ownership

Funds ownership: 92.87%90.05% (-2.8%)

Holders
1,063
Holders Change
+37
Holders Change %
+3.61%
% of All Funds
14%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.13%
New
129
Increased
393
Reduced
392
Closed
79
Calls
$57.4M
Puts
$20.6M
Net Calls
+$36.8M
Net Calls Change
-$16.5M

XYL Hedge Fund Activity: Q2 2025 in Review

1,063 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q2 2025, worth a combined $28.3B — up 5.3% from $26.9B a quarter earlier.

Buyers outnumbered sellers: 129 funds opened new XYL positions and 79 closed out — a net gain of 50 holders — while 393 added to existing stakes and 392 trimmed.

The largest buyer was Amundi, adding an estimated $101M. The largest seller was Aristotle Capital Management, cutting an estimated $958M.

  • 1,063 institutional investors held Xylem (XYL) as of Q2 2025, up from 1,026 in Q1 2025.
  • Funds reported $28.3B of Xylem stock for Q2 2025, up 5.3% quarter-over-quarter.
  • 129 funds opened new Xylem positions in Q2 2025 and 79 closed out, a net change of +50 holders.
  • The largest Xylem buyer in Q2 2025 was Amundi, an estimated $101M added.
  • The largest Xylem seller in Q2 2025 was Aristotle Capital Management, an estimated $958M sold.

Based on aggregated 13F filings for Q2 2025.